Norgine Pharmaceuticals is a specialty pharmaceutical firm that develops, manufactures, and markets medications for treating acute and chronic illnesses. Its core focus is on gastroenterology, hepatology, pain management, and incontinence. Its bestselling drug, Movicol (for constipation) brings in more than 50% of sales. Other products include procedural bowel cleansing therapy Moviprep, diarrhea treatment Xifaxan, and Oramorph for cancer-related pain. The company also partners with other companies to develop and commercialize innovative pharmaceuticals. Norgine Pharmaceuticals is a subsidiary of Netherlands-based Norgine BV, which was founded in 1906 and operates manufacturing facilities in France and the UK.